SS Innovations International Inc. continues its world-first telesurgery milestones with the inaugural pediatric pyeloplasty telesurgery, using the company’s SSi Mantra surgical robotic system.

Dr. Chandra Mohan Vaddi, managing director of Preeti Urology & Kidney Hospitals (Preeti Hospital), completed the robotic procedure remotely from SS Innovations’ headquarters in Gurugram, India, nearly 1,000 miles away from a 16-month-old patient located at Preeti Hospital in Hyderabad, India.

“Our SSi Mantra surgical robotic system continues to pioneer new telesurgeries across procedure types. We are thankful for the work of the team members at Preeti Hospital and Dr. Chandra Mohan Vaddi, who utilized the SSi Mantra to perform the world’s first pediatric pyeloplasty telesurgery,” SS Innovations Board Chairman/CEO Dr. Sudhir Srivastava said. “Compared to traditional methods, robotic surgery affords the potential to be more precise, less invasive with smaller incisions, less painful, and quicker with faster recovery times—all important considerations in both the pediatric space and in general surgery. Moreover, as physicians increasingly utilize the SSi Mantra and its telesurgery capabilities to reach patients in rural and remote areas, we further our mission of democratizing advanced surgical robotic care for patients in need.”

To date, doctors have used the SSi Mantra surgical robotic system in more than 50 telesurgeries at distances of up to 4,000 miles to perform procedures in pediatric, cardiac, urology, gynecology, oncology, general surgery practice areas.

SS Innovations strives to address the unmet surgical robotic needs of the pediatrics market, aligning with the company’s mission to provide care to underserved communities. The SSi Mantra surgical robotic system is a user-friendly, modular multi-arm system with many advanced technology features, including three to five modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D diagnostic imaging models. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra uses more than 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures. 

SS Innovations International Inc. develops surgical robotic technologies. Its product range includes the proprietary “SSi Mantra” surgical robotic system and its suite of “SSi Mudra” surgical instruments, which support various surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.